BLACKSBURG, Va., February 16, 2014--In a landmark bipartisan effort, members of Congress announced the 21st Century Cures Initiative in April of 2014. Since then, representatives have been traveling around the country to gain insight into the discovery, development, and delivery phases of medical innovation with the ultimate aim of creating a better, more efficient system.
Last October, representatives Morgan Griffith and Phil Roe brought the conversation to Virginia. They met with key players in the Commonwealth’s life sciences and medical fields to discuss how Virginia can contribute to the acceleration of discovery, development, and delivery.
Conversation focused on issues such as the Food and Drug Administration’s approval process, telemedicine, clinical trials, The intiative—denoted as #Path2Cures on Facebook and Twitter—is devoted to accelerating cures for human disease and approaching healthcare in a way that is preventative, participatory, and cost-effective.
Among those invited was Josep Bassaganya-Riera, director of Virginia Bioinformatics Institute’s Nutritional Immunology and Molecular Medicine Laboratory and founder of BioTherapeutics, Inc.
“As we move forward in the 21st century with all its attendant medical challenges, it is very important that we use the most efficient and cost-effective research methods to achieve our aims,” said Bassaganya-Riera. “One of the most exciting uses of technology in the field today is the combination of computational modeling with experimental work to produce better therapeutic targets more quickly and efficiently. Our work on the Modeling Immunity to Enteric Pathogens has shown that in silico modeling will be foundational to the future of medicine.”
The Energy and Commerce Committee hopes to bring their findings before the House of Representatives in 2015 as a means of garnering more funding for research and the full integration of translational medicine into the U.S. healthcare system.
February 16, 2015